Article
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
International journal of molecular sciences - 28 May 2021
Wessely Anja, Steeb Theresa, Berking Carola, Heppt Markus Vincent
Abstract excerpt
Cutaneous melanoma represents one of the deadliest types of skin cancer. The prognosis strongly depends on the disease stage, thus early detection is crucial. New therapies, including BRAF and MEK inhibitors and immunotherapies, have significantly improved the survival of patients in the last decade. However, intrinsic and acquired resistance is still a challenge. In this review, we discuss two major aspects that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
